352 related articles for article (PubMed ID: 34068996)
1. EnvIRONmental Aspects in Myelodysplastic Syndrome.
Petzer V; Theurl I; Weiss G; Wolf D
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068996
[TBL] [Abstract][Full Text] [Related]
2. [Myelodysplastic syndromes and iron metabolism].
Kawabata H
Rinsho Ketsueki; 2018; 59(10):2042-2049. PubMed ID: 30305507
[TBL] [Abstract][Full Text] [Related]
3. Unraveling the mechanisms behind iron overload and ineffective hematopoiesis in myelodysplastic syndromes.
Angelucci E; Cianciulli P; Finelli C; Mecucci C; Voso MT; Tura S
Leuk Res; 2017 Nov; 62():108-115. PubMed ID: 29054020
[TBL] [Abstract][Full Text] [Related]
4. Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions.
Cui R; Gale RP; Zhu G; Xu Z; Qin T; Zhang Y; Huang G; Li B; Fang L; Zhang H; Pan L; Hu N; Qu S; Xiao Z
Leuk Res; 2014 May; 38(5):545-50. PubMed ID: 24598841
[TBL] [Abstract][Full Text] [Related]
5. Iron overload in myelodysplastic syndromes (MDS).
Gattermann N
Int J Hematol; 2018 Jan; 107(1):55-63. PubMed ID: 29177643
[TBL] [Abstract][Full Text] [Related]
6. Iron overload alters the energy metabolism in patients with myelodysplastic syndromes: results from the multicenter FISM BIOFER study.
Cilloni D; Ravera S; Calabrese C; Gaidano V; Niscola P; Balleari E; Gallo D; Petiti J; Signorino E; Rosso V; Panuzzo C; Sabatini F; Andreani G; Dragani M; Finelli C; Poloni A; Crugnola M; Voso MT; Fenu S; Pelizzari A; Santini V; Saglio G; Podestà M; Frassoni F
Sci Rep; 2020 Jun; 10(1):9156. PubMed ID: 32514107
[TBL] [Abstract][Full Text] [Related]
7. Iron overload impairs normal hematopoietic stem and progenitor cells through reactive oxygen species and shortens survival in myelodysplastic syndrome mice.
Jin X; He X; Cao X; Xu P; Xing Y; Sui S; Wang L; Meng J; Lu W; Cui R; Ni H; Zhao M
Haematologica; 2018 Oct; 103(10):1627-1634. PubMed ID: 29903757
[TBL] [Abstract][Full Text] [Related]
8. Iron chelation improves ineffective erythropoiesis and iron overload in myelodysplastic syndrome mice.
An W; Feola M; Levy M; Aluri S; Ruiz-Martinez M; Sridharan A; Fibach E; Zhu X; Verma A; Ginzburg Y
Elife; 2023 Dec; 12():. PubMed ID: 38153418
[TBL] [Abstract][Full Text] [Related]
9. [Current understanding of iron overload hazard in patients with myelodysplastic syndrome].
Song LX; Su JY; Zhang Z; Chang CK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):484-8. PubMed ID: 23628060
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the understanding of iron overload in sideroblastic myelodysplastic syndrome.
Cuijpers ML; Raymakers RA; Mackenzie MA; de Witte TJ; Swinkels DW
Br J Haematol; 2010 May; 149(3):322-33. PubMed ID: 20067561
[TBL] [Abstract][Full Text] [Related]
11. When is iron overload deleterious, and when and how should iron chelation therapy be administered in myelodysplastic syndromes?
Steensma DP; Gattermann N
Best Pract Res Clin Haematol; 2013 Dec; 26(4):431-44. PubMed ID: 24507819
[TBL] [Abstract][Full Text] [Related]
12. Iron overload promotes erythroid apoptosis through regulating HIF-1a/ROS signaling pathway in patients with myelodysplastic syndrome.
Zheng QQ; Zhao YS; Guo J; Zhao SD; Song LX; Fei CM; Zhang Z; Li X; Chang CK
Leuk Res; 2017 Jul; 58():55-62. PubMed ID: 28460338
[TBL] [Abstract][Full Text] [Related]
13. Iron overload may promote alteration of NK cells and hematopoietic stem/progenitor cells by JNK and P38 pathway in myelodysplastic syndromes.
Hua Y; Wang C; Jiang H; Wang Y; Liu C; Li L; Liu H; Shao Z; Fu R
Int J Hematol; 2017 Aug; 106(2):248-257. PubMed ID: 28405919
[TBL] [Abstract][Full Text] [Related]
14. Intracellular ROS profile in hematopoietic progenitors of MDS patients: association with blast count and iron overload.
Chan LSA; Gu LC; Leitch HA; Wells RA
Hematology; 2021 Dec; 26(1):88-95. PubMed ID: 34000978
[No Abstract] [Full Text] [Related]
15. [Study of abnormal iron metabolism parameters and iron overload in patients with myelodysplastic syndromes].
Song LL; Zheng QQ; Xiao C; Guo J; Wu D; Su JY; Zhou LY; Chang CK
Zhonghua Xue Ye Xue Za Zhi; 2016 Oct; 37(10):903-907. PubMed ID: 27801326
[TBL] [Abstract][Full Text] [Related]
16. Enhanced plasma protein carbonylation in patients with myelodysplastic syndromes.
Hlaváčková A; Štikarová J; Pimková K; Chrastinová L; Májek P; Kotlín R; Čermák J; Suttnar J; Dyr JE
Free Radic Biol Med; 2017 Jul; 108():1-7. PubMed ID: 28300669
[TBL] [Abstract][Full Text] [Related]
17. The Clinical Significance of Iron Overload and Iron Metabolism in Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Weber S; Parmon A; Kurrle N; Schnütgen F; Serve H
Front Immunol; 2020; 11():627662. PubMed ID: 33679722
[TBL] [Abstract][Full Text] [Related]
18. SF3B1-mutated myelodysplastic syndrome with ring sideroblasts harbors more severe iron overload and corresponding over-erythropoiesis.
Zhu Y; Li X; Chang C; Xu F; He Q; Guo J; Tao Y; Liu Y; Liu L; Shi W
Leuk Res; 2016 May; 44():8-16. PubMed ID: 26970172
[TBL] [Abstract][Full Text] [Related]
19. Iron overload in patients with myelodysplastic syndromes: An updated overview.
Moukalled NM; El Rassi FA; Temraz SN; Taher AT
Cancer; 2018 Oct; 124(20):3979-3989. PubMed ID: 29905937
[TBL] [Abstract][Full Text] [Related]
20. Iron overload and its impact on outcome of patients with hematological diseases.
Franke GN; Kubasch AS; Cross M; Vucinic V; Platzbecker U
Mol Aspects Med; 2020 Oct; 75():100868. PubMed ID: 32620237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
